How to survive and thrive during a cost of living crisis

Top tips on managing the cost everyday life from groceries to holidays

Abeona Therapeutics Inc. (0H7R.L)

LSE - LSE Delayed price. Currency in USD

Add to watchlist

0.1510

-0.0293

(-16.25%)

At close: 03:56PM BST

Loading interactive chart…

Zacks
Aerie (AERI) Starts Late-Stage Study to Treat Dry Eye Disease
Aerie Pharmaceutials (AERI) doses the first patient in a phase III study on its investigational TRMP8 agonist drug for the treatment of dry eye disease.
Zacks
Athersys (ATHX) Down as Ischemic Stroke Study Fails to Meet Goal
While a mid-stage/late-stage study evaluating Athersys' (ATHX) stem cell treatment for ischemic stroke misses out on its primary endpoint, top-line data shows evidence of therapeutic impact.
Zacks
Enanta's (ENTA) RSV Drug Fails to Meet Study Goal, Stock Drops
While a mid-stage study evaluating Enanta's (ENTA) RSV candidate misses out on its primary endpoint, a statistically huge number of subjects achieved undetectable RSV RNA at the end of treatment.